PPMD Awards $100,000 in Exploratory Grants

PPMD is thrilled to award two exploratory grants as part of our ongoing grant program. Peter Arthur of the University of Western Australia was awarded $50,000 to finish testing a molecule called procysteine in animal models in preparation for a human clinical trial. Procysteine is an antioxidant that has been tested in other disorders and has been shown to correct some of the defects caused by the lack of dystrophin in mice.

PPMD has also awarded ReveraGen BioPharma an Exploratory Award of $50,000 to determine if small snippets of RNA called "microRNAs" can affect the efficiency of exon-skipping. The investigators will inhibit the microRNAs that seem to be problematic while introducing antisense oligos to stimulate exon skipping. 

Learn more about PPMD's grant program.

Views: 370


You need to be a member of PPMD Community to add comments!

Join PPMD Community

Comment by Sharon Hesterlee on March 25, 2014 at 5:23pm

Hi Amit--I believe they are within a year of starting a trial. 


Comment by amit gupta on March 25, 2014 at 5:07pm

sharon, where is vbp15 on the trial possibility?

Need help using this community site? Visit Ning's Help Page.



© 2021   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service